Benitec Biopharma Inc.
BNTC
$14.61
-$0.33-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.35M | -7.36M | -5.06M | -4.72M | -4.28M |
| Total Depreciation and Amortization | 106.00K | 81.00K | 91.00K | 91.00K | 90.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.60M | 179.00K | 435.00K | 454.00K | 192.00K |
| Change in Net Operating Assets | 3.57M | -606.00K | -53.00K | 882.00K | -2.17M |
| Cash from Operations | -3.09M | -7.70M | -4.59M | -3.29M | -6.17M |
| Capital Expenditure | -6.00K | -12.00K | -- | 0.00 | -179.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -12.00K | -- | 0.00 | -179.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 17.87M | 21.66M | 43.00M | -- |
| Repurchase of Common Stock | -9.07M | -- | -- | -- | -39.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 37.48M | -2.00K | -- | -2.93M | 39.00K |
| Cash from Financing | 28.41M | 17.87M | 21.66M | 40.07M | 0.00 |
| Foreign Exchange rate Adjustments | -21.00K | 283.00K | -93.00K | -5.00K | 115.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.30M | 10.44M | 16.98M | 36.77M | -6.23M |